| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 3.04e-04 | 14 | 39 | 2 | GO:0071735 | |
| Domain | Ubiquilin-1/2 | 3.22e-06 | 2 | 34 | 2 | IPR028430 | |
| Domain | Ubiquilin | 4.80e-05 | 6 | 34 | 2 | IPR015496 | |
| Domain | STI1_HS-bd | 1.43e-04 | 10 | 34 | 2 | IPR006636 | |
| Domain | STI1 | 1.43e-04 | 10 | 34 | 2 | SM00727 | |
| Domain | 6-PGluconate_DH_C-like | 5.39e-04 | 19 | 34 | 2 | IPR008927 | |
| Domain | UBA | 1.36e-03 | 30 | 34 | 2 | SM00165 | |
| Domain | GPS | 1.74e-03 | 34 | 34 | 2 | SM00303 | |
| Domain | GPS | 1.84e-03 | 35 | 34 | 2 | PF01825 | |
| Domain | UBA | 1.95e-03 | 36 | 34 | 2 | PF00627 | |
| Domain | GPS | 1.95e-03 | 36 | 34 | 2 | PS50221 | |
| Domain | GPS | 2.06e-03 | 37 | 34 | 2 | IPR000203 | |
| Domain | UBIQUITIN_1 | 2.06e-03 | 37 | 34 | 2 | PS00299 | |
| Domain | UBQ | 2.77e-03 | 43 | 34 | 2 | SM00213 | |
| Domain | UBA | 2.90e-03 | 44 | 34 | 2 | IPR015940 | |
| Domain | UBA | 3.30e-03 | 47 | 34 | 2 | PS50030 | |
| Domain | ubiquitin | 3.30e-03 | 47 | 34 | 2 | PF00240 | |
| Domain | CUB | 4.18e-03 | 53 | 34 | 2 | PS01180 | |
| Domain | C1-set | 4.34e-03 | 54 | 34 | 2 | PF07654 | |
| Domain | UBIQUITIN_2 | 4.34e-03 | 54 | 34 | 2 | PS50053 | |
| Domain | IGc1 | 4.66e-03 | 56 | 34 | 2 | SM00407 | |
| Domain | CUB_dom | 4.82e-03 | 57 | 34 | 2 | IPR000859 | |
| Domain | Ig_C1-set | 4.99e-03 | 58 | 34 | 2 | IPR003597 | |
| Domain | Ig/MHC_CS | 4.99e-03 | 58 | 34 | 2 | IPR003006 | |
| Domain | Ubiquitin_dom | 4.99e-03 | 58 | 34 | 2 | IPR000626 | |
| Domain | IG_MHC | 5.33e-03 | 60 | 34 | 2 | PS00290 | |
| Domain | RhoGAP | 5.68e-03 | 62 | 34 | 2 | SM00324 | |
| Domain | RhoGAP | 5.86e-03 | 63 | 34 | 2 | PF00620 | |
| Domain | UBA-like | 6.04e-03 | 64 | 34 | 2 | IPR009060 | |
| Domain | RHOGAP | 6.04e-03 | 64 | 34 | 2 | PS50238 | |
| Domain | RhoGAP_dom | 6.04e-03 | 64 | 34 | 2 | IPR000198 | |
| Domain | - | 6.04e-03 | 64 | 34 | 2 | 1.10.555.10 | |
| Domain | SPRY | 1.09e-02 | 87 | 34 | 2 | SM00449 | |
| Domain | Rho_GTPase_activation_prot | 1.12e-02 | 88 | 34 | 2 | IPR008936 | |
| Domain | SPRY | 1.27e-02 | 94 | 34 | 2 | PF00622 | |
| Domain | SPRY_dom | 1.27e-02 | 94 | 34 | 2 | IPR003877 | |
| Domain | B30.2/SPRY | 1.29e-02 | 95 | 34 | 2 | IPR001870 | |
| Domain | B302_SPRY | 1.29e-02 | 95 | 34 | 2 | PS50188 | |
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 1703205 | ||
| Pubmed | Diaphanospondylodysostosis: six new cases and exclusion of the candidate genes, PAX1 and MEOX1. | 1.23e-06 | 2 | 39 | 2 | 17764081 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 29247619 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 1760403 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 35063704 | ||
| Pubmed | Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy. | 3.67e-06 | 3 | 39 | 2 | 20529957 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 17098253 | ||
| Pubmed | Homeodomain proteins Mox1 and Mox2 associate with Pax1 and Pax3 transcription factors. | 7.34e-06 | 4 | 39 | 2 | 11423130 | |
| Pubmed | Analysis of VpreB expression during B lineage differentiation in lambda5-deficient mice. | 7.34e-06 | 4 | 39 | 2 | 11564789 | |
| Pubmed | VpreB serves as an invariant surrogate antigen for selecting immunoglobulin antigen-binding sites. | 7.34e-06 | 4 | 39 | 2 | 28217764 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 8624804 | ||
| Pubmed | Organization of the murine Ig-related lambda 5 gene transcribed selectively in pre-B lymphocytes. | 7.34e-06 | 4 | 39 | 2 | 3107979 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 19084434 | ||
| Pubmed | Loss of early B cell protein λ5 decreases bone mass and accelerates skeletal aging. | 7.34e-06 | 4 | 39 | 2 | 36189270 | |
| Pubmed | Conservation of the immunoglobulin C lambda 5 gene in the Mus gene. | 7.34e-06 | 4 | 39 | 2 | 3129289 | |
| Pubmed | The nonimmunoglobulin portion of lambda5 mediates cell-autonomous pre-B cell receptor signaling. | 7.34e-06 | 4 | 39 | 2 | 12897780 | |
| Pubmed | PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation. | 7.34e-06 | 4 | 39 | 2 | 19148225 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 8548286 | ||
| Pubmed | Genomic suppression of murine B29/Ig-beta promoter-driven transgenes. | 7.34e-06 | 4 | 39 | 2 | 17111355 | |
| Pubmed | Lambda 5, a new light-chain-related locus selectively expressed in pre-B lymphocytes. | 7.34e-06 | 4 | 39 | 2 | 3024017 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 36423739 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 1591779 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 3128472 | ||
| Pubmed | B-1a cells acquire their unique characteristics by bypassing the pre-BCR selection stage. | 7.34e-06 | 4 | 39 | 2 | 31628339 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 36827983 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 16813565 | ||
| Pubmed | Isolation of a cDNA copy of an RNA species expressed in murine pre-B cells. | 7.34e-06 | 4 | 39 | 2 | 2430794 | |
| Pubmed | Gamma 2b provides only some of the signals normally given via mu in B cell development. | 7.34e-06 | 4 | 39 | 2 | 9088980 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 7684685 | ||
| Pubmed | Distorted antibody repertoire developed in the absence of pre-B cell receptor formation. | 7.34e-06 | 4 | 39 | 2 | 29191653 | |
| Pubmed | lambda 5, but not mu, is required for B cell maturation in a unique gamma 2b transgenic mouse line. | 7.34e-06 | 4 | 39 | 2 | 7869028 | |
| Pubmed | A unique role for the lambda5 nonimmunoglobulin tail in early B lymphocyte development. | 7.34e-06 | 4 | 39 | 2 | 18713994 | |
| Pubmed | Herp enhances ER-associated protein degradation by recruiting ubiquilins. | 7.34e-06 | 4 | 39 | 2 | 18307982 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 10620602 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 19109144 | ||
| Pubmed | The 14.1 surrogate light chain promoter has lineage- and stage-restricted activity. | 7.34e-06 | 4 | 39 | 2 | 9029104 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 25546233 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 8156589 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 15975090 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 15024065 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 8625987 | ||
| Pubmed | Mapping and functional analysis of regulatory sequences in the mouse lambda5-VpreB1 domain. | 1.22e-05 | 5 | 39 | 2 | 15950724 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 7650380 | ||
| Pubmed | Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor. | 1.22e-05 | 5 | 39 | 2 | 11172022 | |
| Pubmed | Clonal relationships of memory B cell subsets in autoimmune mice. | 1.22e-05 | 5 | 39 | 2 | 36936947 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 9858590 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 8453664 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 3003227 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 10549293 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 19011159 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 20116104 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 15972669 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 12055243 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 15713636 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 8808678 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 3117530 | ||
| Pubmed | Structural studies of the interaction between ubiquitin family proteins and proteasome subunit S5a. | 1.22e-05 | 5 | 39 | 2 | 11827521 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 8046237 | ||
| Pubmed | Lambda5 is required for rearrangement of the Ig kappa light chain gene in pro-B cell lines. | 1.83e-05 | 6 | 39 | 2 | 10421777 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 1730258 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 22566564 | ||
| Pubmed | Disruption of the preB Cell Receptor Complex Leads to Decreased Bone Mass. | 1.83e-05 | 6 | 39 | 2 | 31552025 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 14500626 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 35247097 | ||
| Pubmed | Pax1 and Pax9 activate Bapx1 to induce chondrogenic differentiation in the sclerotome. | 1.83e-05 | 6 | 39 | 2 | 12490554 | |
| Pubmed | Expression of the proliferation-related Ki-67 mRNA in the early development of murine embryo. | 1.83e-05 | 6 | 39 | 2 | 9196061 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 14638847 | ||
| Pubmed | System to identify individual somites and their derivatives in the developing mouse embryo. | 1.83e-05 | 6 | 39 | 2 | 9389448 | |
| Pubmed | The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. | 2.56e-05 | 7 | 39 | 2 | 10983987 | |
| Pubmed | IL-2 receptor alpha chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. | 2.56e-05 | 7 | 39 | 2 | 7526894 | |
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 9058795 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 9664688 | ||
| Pubmed | Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions. | 2.56e-05 | 7 | 39 | 2 | 23774650 | |
| Pubmed | Mouse mutant "rib-vertebrae" (rv): a defect in somite polarity. | 2.56e-05 | 7 | 39 | 2 | 11002339 | |
| Pubmed | Ubiquilins Chaperone and Triage Mitochondrial Membrane Proteins for Degradation. | 2.56e-05 | 7 | 39 | 2 | 27345149 | |
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 10508254 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 20059542 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 25727904 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 8100803 | ||
| Pubmed | Efficient generation of B lymphocytes by recognition of self-antigens. | 2.56e-05 | 7 | 39 | 2 | 21604259 | |
| Pubmed | The ubiquitin-like protein PLIC-2 is a negative regulator of G protein-coupled receptor endocytosis. | 2.56e-05 | 7 | 39 | 2 | 18199683 | |
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 30664872 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 18535780 | ||
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 25907116 | ||
| Pubmed | Maintenance of somite borders in mice requires the Delta homologue DII1. | 3.42e-05 | 8 | 39 | 2 | 9109488 | |
| Pubmed | Ubiquilin4 is an adaptor protein that recruits Ubiquilin1 to the autophagy machinery. | 3.42e-05 | 8 | 39 | 2 | 23459205 | |
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 10906147 | ||
| Pubmed | Failure of B-cell differentiation in mice lacking the transcription factor EBF. | 4.39e-05 | 9 | 39 | 2 | 7542362 | |
| Pubmed | Severe defects in the formation of epaxial musculature in open brain (opb) mutant mouse embryos. | 4.39e-05 | 9 | 39 | 2 | 8565855 | |
| Pubmed | 4.39e-05 | 9 | 39 | 2 | 29907570 | ||
| Pubmed | 4.39e-05 | 9 | 39 | 2 | 9545534 | ||
| Pubmed | Follistatin interacts with Noggin in the development of the axial skeleton. | 5.48e-05 | 10 | 39 | 2 | 24514266 | |
| Pubmed | 5.48e-05 | 10 | 39 | 2 | 8001125 | ||
| Pubmed | The mouse pudgy mutation disrupts Delta homologue Dll3 and initiation of early somite boundaries. | 5.48e-05 | 10 | 39 | 2 | 9662403 | |
| Pubmed | Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates. | 5.68e-05 | 66 | 39 | 3 | 24811749 | |
| Pubmed | 6.70e-05 | 11 | 39 | 2 | 27272319 | ||
| Pubmed | 6.70e-05 | 11 | 39 | 2 | 10477673 | ||
| Pubmed | 6.70e-05 | 11 | 39 | 2 | 9242490 | ||
| Pubmed | PAQR9 Modulates BAG6-mediated protein quality control of mislocalized membrane proteins. | 8.03e-05 | 12 | 39 | 2 | 31904842 | |
| Pubmed | 9.48e-05 | 13 | 39 | 2 | 8226859 | ||
| Interaction | IGLL1 interactions | 1.24e-06 | 12 | 37 | 3 | int:IGLL1 | |
| Interaction | SMIM2 interactions | 9.83e-06 | 3 | 37 | 2 | int:SMIM2 | |
| Interaction | DEFB115 interactions | 9.83e-06 | 3 | 37 | 2 | int:DEFB115 | |
| Interaction | FZD7 interactions | 1.18e-05 | 77 | 37 | 4 | int:FZD7 | |
| Interaction | PAX1 interactions | 1.96e-05 | 4 | 37 | 2 | int:PAX1 | |
| Interaction | GUCA2B interactions | 3.27e-05 | 5 | 37 | 2 | int:GUCA2B | |
| Interaction | C1QTNF4 interactions | 4.90e-05 | 6 | 37 | 2 | int:C1QTNF4 | |
| Interaction | SMIM19 interactions | 6.85e-05 | 7 | 37 | 2 | int:SMIM19 | |
| Interaction | ASCL1 interactions | 7.67e-05 | 45 | 37 | 3 | int:ASCL1 | |
| Interaction | GPR162 interactions | 9.12e-05 | 8 | 37 | 2 | int:GPR162 | |
| Interaction | WFDC12 interactions | 9.12e-05 | 8 | 37 | 2 | int:WFDC12 | |
| Interaction | NDOR1 interactions | 1.73e-04 | 59 | 37 | 3 | int:NDOR1 | |
| Interaction | CDH17 interactions | 1.79e-04 | 11 | 37 | 2 | int:CDH17 | |
| Interaction | PLAAT3 interactions | 1.79e-04 | 11 | 37 | 2 | int:PLAAT3 | |
| Interaction | SEZ6L interactions | 1.79e-04 | 11 | 37 | 2 | int:SEZ6L | |
| Interaction | RTL8A interactions | 1.79e-04 | 11 | 37 | 2 | int:RTL8A | |
| Interaction | PAQR9 interactions | 1.79e-04 | 11 | 37 | 2 | int:PAQR9 | |
| Interaction | ZFAND2B interactions | 1.81e-04 | 60 | 37 | 3 | int:ZFAND2B | |
| Interaction | RNF185 interactions | 1.96e-04 | 158 | 37 | 4 | int:RNF185 | |
| Interaction | KRTAP12-1 interactions | 2.10e-04 | 63 | 37 | 3 | int:KRTAP12-1 | |
| Interaction | ZG16 interactions | 2.14e-04 | 12 | 37 | 2 | int:ZG16 | |
| Interaction | PLAAT2 interactions | 2.53e-04 | 13 | 37 | 2 | int:PLAAT2 | |
| Interaction | RTL8B interactions | 2.53e-04 | 13 | 37 | 2 | int:RTL8B | |
| Interaction | SOD3 interactions | 2.53e-04 | 13 | 37 | 2 | int:SOD3 | |
| Interaction | JPH4 interactions | 2.63e-04 | 68 | 37 | 3 | int:JPH4 | |
| Interaction | CHRNB4 interactions | 3.11e-04 | 72 | 37 | 3 | int:CHRNB4 | |
| Interaction | GUCA2A interactions | 3.87e-04 | 16 | 37 | 2 | int:GUCA2A | |
| Interaction | COL9A2 interactions | 4.38e-04 | 17 | 37 | 2 | int:COL9A2 | |
| Interaction | NPY interactions | 4.93e-04 | 18 | 37 | 2 | int:NPY | |
| Interaction | NBL1 interactions | 4.93e-04 | 18 | 37 | 2 | int:NBL1 | |
| Interaction | SERPINI2 interactions | 4.93e-04 | 18 | 37 | 2 | int:SERPINI2 | |
| Interaction | CDIP1 interactions | 4.93e-04 | 18 | 37 | 2 | int:CDIP1 | |
| Interaction | PRAP1 interactions | 4.93e-04 | 18 | 37 | 2 | int:PRAP1 | |
| Interaction | RBMS1 interactions | 5.48e-04 | 207 | 37 | 4 | int:RBMS1 | |
| Interaction | CSN3 interactions | 5.50e-04 | 19 | 37 | 2 | int:CSN3 | |
| Interaction | TDRD3 interactions | 5.99e-04 | 212 | 37 | 4 | int:TDRD3 | |
| Interaction | SRGN interactions | 6.10e-04 | 20 | 37 | 2 | int:SRGN | |
| Interaction | PIK3IP1 interactions | 6.74e-04 | 21 | 37 | 2 | int:PIK3IP1 | |
| Interaction | KHNYN interactions | 6.74e-04 | 21 | 37 | 2 | int:KHNYN | |
| Interaction | PRRC2A interactions | 6.85e-04 | 389 | 37 | 5 | int:PRRC2A | |
| Interaction | MEX3B interactions | 7.12e-04 | 222 | 37 | 4 | int:MEX3B | |
| Interaction | SMR3B interactions | 7.40e-04 | 22 | 37 | 2 | int:SMR3B | |
| Interaction | CCL7 interactions | 7.40e-04 | 22 | 37 | 2 | int:CCL7 | |
| Interaction | BPIFA1 interactions | 7.68e-04 | 98 | 37 | 3 | int:BPIFA1 | |
| Cytoband | 16p13.3 | 1.18e-03 | 244 | 39 | 3 | 16p13.3 | |
| GeneFamily | Ubiquilin family | 1.83e-05 | 5 | 25 | 2 | 783 | |
| GeneFamily | C1-set domain containing | 1.53e-03 | 42 | 25 | 2 | 591 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Hsd11b1_Endou|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.09e-05 | 158 | 39 | 4 | c8af8964a140acb2987e3b4906d72c546108d229 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-05 | 160 | 39 | 4 | 830f17bad94de05612fe6d53d39e42a4b3f3e2f3 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-05 | 160 | 39 | 4 | 18ae6822915d16699beb9047baeef9b006901a35 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.91e-05 | 182 | 39 | 4 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-05 | 185 | 39 | 4 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.21e-05 | 189 | 39 | 4 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 2.71e-05 | 199 | 39 | 4 | f30e9d3d095a1e12d759debe27540aad32861db6 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.76e-05 | 200 | 39 | 4 | 501a3b93624df463458a35d3e6648d4ccc941724 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.76e-05 | 200 | 39 | 4 | d1f36a8232411933b1494168ec912fd0e5246428 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Klk6_(Klk6)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.14e-05 | 96 | 39 | 3 | 0fc179af7370a29b7bd5d81e1302a479ae72f196 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O2-Trf|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.14e-05 | 96 | 39 | 3 | c301ecfd67ece8bb12be1b94b614957a58046457 | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Mbp_(Mbp)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.14e-05 | 96 | 39 | 3 | 9673d03916705c675686bb4282dedd3dc5e98625 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.14e-05 | 96 | 39 | 3 | 7d402d543ff159c9bb84c00b083e6e18fc0ff786 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Klk6_(Klk6)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.14e-05 | 96 | 39 | 3 | a48235df1f5526ce3ffc4c0c2ba038eb20229c55 | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Mbp_(Mbp)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.14e-05 | 96 | 39 | 3 | 7e2810f5f5a17fcc7ae40edfd3e885740b575e29 | |
| Computational | Neighborhood of CSNK1D | 3.07e-05 | 32 | 21 | 3 | GCM_CSNK1D | |
| Disease | amyotrophic lateral sclerosis type 15 (implicated_via_orthology) | 4.34e-06 | 3 | 36 | 2 | DOID:0060206 (implicated_via_orthology) | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 9.48e-05 | 12 | 36 | 2 | DOID:9255 (implicated_via_orthology) | |
| Disease | parental longevity | 3.17e-04 | 494 | 36 | 5 | EFO_0007796 | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 6.16e-04 | 30 | 36 | 2 | DOID:332 (implicated_via_orthology) | |
| Disease | wellbeing measurement, alcohol consumption measurement | 3.70e-03 | 74 | 36 | 2 | EFO_0007869, EFO_0007878 | |
| Disease | monocyte count | 4.88e-03 | 1320 | 36 | 6 | EFO_0005091 | |
| Disease | mean fractional anisotropy measurement | 6.02e-03 | 95 | 36 | 2 | EFO_0008399 | |
| Disease | colorectal cancer | 6.09e-03 | 604 | 36 | 4 | MONDO_0005575 | |
| Disease | smoking behavior | 8.24e-03 | 341 | 36 | 3 | EFO_0004318 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CERQRGSDPPWELPP | 26 | Q9NXW9 | |
| CRCRPGWQPIPGSPN | 186 | P48960 | |
| AGRARCVWDPPRPQP | 276 | Q76LX8 | |
| DPPWPRVSPACAGRF | 146 | Q16790 | |
| SLQPPAPVWGCLRNP | 11 | P50221 | |
| SGRPEPQSPRPQSWA | 21 | Q8N907 | |
| PKRPPNCARGSCPWD | 261 | A6NDP7 | |
| LQPSPQRADPRCWPR | 6 | A0A0A0MT76 | |
| NGHPPRPWPCPQENR | 46 | Q5VZ46 | |
| PAPNRPRDDSWSVGP | 286 | Q8WWR8 | |
| VPGPARRAQAPPEEW | 51 | Q8IZP7 | |
| GARPASPQAQPCLWP | 501 | P15863 | |
| PQALPQARPCPGRWF | 101 | Q6PRD7 | |
| EAPGEPGPNLRQRWP | 11 | P15814 | |
| LLQPSPQRADPRCWP | 71 | B9A064 | |
| PRYGSPPQRDPNWNG | 261 | O15234 | |
| SGEQWQPPRPAPLAA | 176 | Q8TDN4 | |
| DPPNWNIRPNSRADG | 6 | Q96BQ5 | |
| PAPARACQLPSEWRP | 16 | Q9BQI4 | |
| WNRTAPASRGPEPPE | 71 | O75751 | |
| PPSPGLNWEQPQAAR | 3521 | P98161 | |
| PQLQDAWRGPREPGP | 2586 | P58107 | |
| PGPSLRPPNVACWRD | 166 | Q9Y520 | |
| NDTCPELPPPEWGWR | 641 | Q6UXD5 | |
| GPRCPSPQNLSPWDR | 406 | E7EW31 | |
| SGLEPWLNCDPNPPD | 256 | Q01968 | |
| EGWERAGQCPPPPER | 511 | Q8IY92 | |
| RPPGPQRCREQSDWA | 126 | Q9NRU3 | |
| WERGPENLPPSTGPC | 3146 | Q15413 | |
| PRDGCSPRRPFPWQG | 26 | Q9P227 | |
| PSRTENRDPLPNPWA | 311 | Q9UMX0 | |
| PNNFARSWPCPNPLP | 231 | A6NCN8 | |
| PPPDLGAQRRHGWNP | 36 | Q99619 | |
| NPPTNPPGACQLWEL | 1331 | Q9ULM0 | |
| NPDSPRRPWLGCPQD | 26 | Q6ZNB5 | |
| QPSRTENRDPLPNPW | 306 | Q9UHD9 | |
| GCRNPPPQPVDWNND | 496 | O94900 | |
| SPWDGRDPQEPLPAC | 116 | A6NP61 | |
| RLRQLQGCPWAPGPA | 331 | Q9BRZ2 |